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The European Society of Clinical Microbiology
and Infectious Diseases (ESCMID) supports Study
Groups engaged in the advancement of scientific
knowledge and the dissemination of professional
guidelines in different fields of clinical microbio-
logy and infectious diseases. The Society supports
the activities of ESCMID Study Groups by: (i)
reviewing proposals for symposia ⁄workshops to
be included as part of the scientific programme of
the European Congresses of Clinical Microbiology
and Infectious Diseases (ECCMIDs) and provi-
ding logistic and partial financial support; (ii)
providing promotion of and partial financial
support to scientific meetings organised by
Study Groups; (iii) hosting an annual Study
Group assembly of members during the
ECCMIDs; (iv) providing competitive start-up
grants to selected scientific projects; (v) providing
annual funds to help cover administrative ex-
penses; (vi) supporting postgraduate training
courses organised by individual Study Groups
through administrative grants, as well as attend-
ance grants provided to individual participants;
(vii) publishing announcements and reports of
Study Group activities in the Society’s newsletter
and on its website; (viii) publishing guidelines,
research papers and reviews in Clinical Microbio-
logy and Infection (CMI).
The ESCMID Study Group on Nosocomial
Infections (ESGNI) is involved in all aspects of
nosocomial infections and infection control. The
Study Group has engagedmembers to write a CMI
supplement on infections caused by emerging
pathogenic bacteria, such as betalactam-resistant
enterobacteria, multiresistant Pseudomonas aerugi-
nosa, methicillin-resistant Staphylococcus aureus,
vancomycin-resistant enterococci and Clostridium
difficile. The supplement is supported by unre-
stricted educational grants from Wyeth and
ESCMID.
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